Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SUTRO BIOPHARMA, INC. | Director | Stock Option (Right to Buy) | 29K | Aug 8, 2024 | Direct | ||
Sierra Oncology, Inc. | Chief Financial Officer | Stock Option (right to buy) | 0 | Jul 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STRO | SUTRO BIOPHARMA, INC. | Aug 8, 2024 | 2 | $0 | 4 | Aug 12, 2024 | Director |
STRO | SUTRO BIOPHARMA, INC. | Aug 8, 2024 | 0 | $0 | 3 | Aug 12, 2024 | Director |
SRRA | Sierra Oncology, Inc. | Jul 1, 2022 | 11 | $0 | 4 | Jul 1, 2022 | Chief Financial Officer |
SRRA | Sierra Oncology, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Chief Financial Officer |
SRRA | Sierra Oncology, Inc. | Mar 14, 2022 | 1 | $0 | 4 | Mar 14, 2022 | Chief Financial Officer |
SRRA | Sierra Oncology, Inc. | Jan 28, 2022 | 1 | $0 | 4 | Jan 28, 2022 | Chief Financial Officer |